Effectiveness of Rehabilitation in Adults Suffering From Persistent Concussion Symptoms

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Oct 2, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how personalized rehabilitation treatments can help adults who are experiencing ongoing symptoms after a concussion, known as postconcussion syndrome. The goal is to see if tailored therapies based on individual assessments can lead to better recovery compared to standard treatments. Participants will be asked to complete questionnaires and undergo brain activity tests before and after treatment to measure their progress.

To join the study, you must be at least 21 years old and have a diagnosis of postconcussion syndrome, which means you need to have experienced at least three common symptoms for more than a month after your concussion. The trial will last for 12 weeks, during which you will first receive one type of therapy for six weeks and then switch to another for the next six weeks. It’s important to know that some people may not be eligible due to certain health conditions or if they have been involved in legal cases related to their injury. If you fit the criteria, this trial could provide you with a chance to receive personalized care while contributing to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 21-years and older
• • meet the definition of postconcussion syndrome, which requires a participant to report any 3 symptoms or more (from an inclusive list of 40 most commonly reported persisting symptoms) lasting at least 1-month following the diagnosis of a concussion. Concussion was defined according to the 5th International Consensus Statement on Concussion in Sport.
• • Have adequate language skills in English to read and take part in rehabilitation treatment program.
• Exclusion Criteria:
• • In-patients at Toronto Rehabilitation Institute or any other affiliated University Health Network clinics.
• • Participants will be excluded should their clinical examination be unremarkable for objective physical impairments,
• • Have a chronic infectious disease,
• • Uncontrolled hypertension,
• • Other neurological disorders (not attributed to their primary diagnosis),
• • Cancer treatment (other than basal cell carcinoma), craniotomy, or refractory subdural hematoma long-term use of psychoactive medications that would compromise their ability to comprehend and perform study activities, those with pacemakers or elevated cardiovascular risk,
• • Ongoing litigation surrounding their injury,
• • Have been diagnosed with a moderate or severe brain injury prior to enrolment, post-concussive symptoms persisting beyond 12-months.